Binge eating in ADHD may not be impulsivity-related

The disinhibited binge eating style often seen in individuals with high ADHD symptoms is attributable to a heightened neural reward response to food rather than to the impulsivity that’s a core feature of ADHD, Elizabeth Martin, MSc, reported at the virtual congress of the European College of Neuropsychopharmacology.

Read More

What to do if a child with ADHD cannot sleep

The relationship between ADHD symptoms and sleep problems can create a cycle that is challenging for children and their parents and caregivers. However, many strategies can help kids with ADHD have better sleep. In this article, we look at the relationship between ADHD and sleep, techniques for improving sleep, and when to seek support from…

Read More

Ending the mental health stigma in the tech community

Michael Freeman, a psychiatrist and former CEO who serves on the faculty of the University of California San Francisco School of Medicine, investigated the prevalence and characteristics of mental health conditions among entrepreneurs. He concluded founders are twice as likely to suffer from depression, six times more likely to suffer from ADHD, three times more…

Read More

It’s game on for Akili as it launches digital campaign for first FDA-approved ADHD video game

Akili’s newly launched treatment for ADHD is a prescription—but not a drug. It’s a video game. And the company is taking a fittingly digital approach to launching the first-of-its-kind FDA-approved product. The company’s consumer marketing campaign for the EndeavorRx game centers on social media, while its distribution relies on a digital-first model. The consumer campaign,…

Read More

FDA Approves Updated Prescribing Information for Extended-Release ADHD Drug

Methylphenidate hydrochloride (Adhansia XR) was originally approved in 2019 for ADHD patients at least 6 years old. The US Food and Drug Administration (FDA) has approved updated prescribing information for methylphenidate hydrochloride (Adhansia XR) extended-release capsules CII as a treatment for attention deficit/hyperactivity disorder (ADHD).

Read More

Participation in after-school activities decreases ADHD severity

An analysis of data from the National Survey of Children’s Health for about 4000 children revealed that in children with attention-deficit/hyperactivity disorder (ADHD), participation in after-school activities is associated with decreased ADHD severity and less school absenteeism.

Read More

Personalized at-home neurofeedback compared to long-acting methylphenidate in children with ADHD: NEWROFEED, a European randomized noninferiority trial

For the treatment of attention-deficit hyperactivity disorder (ADHD), one of the promising interventions is neurofeedback. In NEWROFEED, a prospective, multicentre, randomized (3:2), reference drug-controlled trial, researchers assessed the noninferiority of personalized at-home neurofeedback (NF) training vs methylphenidate in the treatment of children with ADHD…Read the full article on Journal of Child Psychology and Psychiatry.

Read More

Managing attention deficit disorder by training the brain

Scientists explored a technique called ‘neurofeedback,’ which enables ADHD patients to train their attention, based on instant feedback from the level of their brain activity. The team of neuroscientists found that not only did the training have a positive effect on patients’ concentration abilities, but also that the attention improvement was closely linked to an…

Read More